Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Journal of Clinical Medicine|November 17, 2019
Elevated Serum 25-Hydroxyvitamin D Levels Are Associated with Improved Bone Formation and Micro-Structural Measures in Elderly Hip Fracture PatientsDeepti K Sharma, Rebecca K Sawyer, Thomas S Robertson, et al.
The Journal of Arthroplasty|August 2, 2011
A preclinical study of stem subsidence and graft incorporation after femoral impaction grafting using porous hydroxyapatite as a bone graft extenderDonald W Howie, Margaret A McGee, Stuart A Callary, et al.
Proteomics|March 19, 2016
MALDI mass spectrometry imaging of N-glycans on tibial cartilage and subchondral bone proteins in knee osteoarthritisMatthew T Briggs, Julia S Kuliwaba, Dzenita Muratovic, et al.
The American Journal of Pathology|March 21, 2020
Current Concepts of Osteomyelitis: From Pathologic Mechanisms to Advanced Research MethodsMarloes I Hofstee, Gowrishankar Muthukrishnan, Gerald J Atkins, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 23, 2018
Time dependent loss of trabecular bone in human tibial plateau fracturesLucian B Solomon, David Kitchen, Paul H Anderson, et al.
Molecular Cancer Therapeutics|October 8, 2009
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 7, 2010
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoIrene Zinonos, Agatha Labrinidis, Michelle Lee, et al.
International Journal of Cancer|March 22, 2006
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAILLisa M Butler, Vasilios Liapis, Stelios Bouralexis, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 7, 2017
Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone lossYolandi Starczak, Daniel C Reinke, Kate R Barratt, et al.
Pageof 17